Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€85.99
17.04.21
€98.00
17.04.22
19.71%
18.04.22

buy
Bayer AG

Start price
Target price
Perf. (%)
€53.41
22.03.21
€58.00
22.03.22
11.35%
23.03.22

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€29.88
21.03.21
€35.00
21.03.22
64.07%
22.03.22

buy
Aveo Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€3.64
09.01.22
€4.00
09.01.23
37.21%
21.03.22

buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.015
20.02.22
€7.50
20.03.22
61900.00%
21.03.22

Could be worthwhile Investment >10% per year
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€115.90
16.12.21
€120.00
16.03.22
23.37%
16.03.22

buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€11.37
17.06.21
€18.00
09.03.22
95.60%
10.03.22

Could be very worthwhile Investment >20% year
buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€83.63
10.03.21
€62.35
10.03.22
28.85%
10.03.22

buy
Valneva SE

Start price
Target price
Perf. (%)
€10.68
07.03.21
€11.00
07.03.22
26.50%
07.03.22

buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€79.50
02.03.21
€100.00
02.03.22
41.13%
03.03.22

buy
Epizyme Inc.

Start price
Target price
Perf. (%)
€1.10
27.01.22
€1.00
27.01.23
41.00%
05.02.22

Could be worthwhile Investment >10% per year
Capable Management
Bad culture
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€463.95
25.01.21
€500.00
25.01.22
15.42%
26.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€132.40
14.01.21
€144.00
14.01.22
10.89%
15.01.22

buy
Catalyst Pharmaceutical Partners Inc

Start price
Target price
Perf. (%)
€2.84
05.01.21
€3.50
05.01.22
100.71%
06.01.22

buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€46.03
04.01.21
€60.00
04.01.22
115.51%
05.01.22

buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€137.00
03.01.21
€150.00
03.01.22
50.37%
04.01.22

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€125.32
28.12.20
€140.00
28.12.21
20.17%
29.12.21

buy
MannKind Corp.

Start price
Target price
Perf. (%)
€2.99
16.12.20
€3.50
16.12.21
20.27%
17.12.21

Biogen Inc.

Start price
Target price
Perf. (%)
€243.10
18.10.21
€210.00
02.01.23
-12.53%
16.12.21

Could be worthwhile Investment >10% per year
buy
Amphastar Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€15.30
15.12.20
€18.00
15.12.21
28.10%
16.12.21

buy
Dare Bioscience Inc.

Start price
Target price
Perf. (%)
€1.06
13.12.20
€1.20
13.12.21
47.17%
14.12.21

buy
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€4.95
10.10.21
€8.00
31.12.23
58.11%
13.12.21

Could be very worthwhile Investment >20% year
buy
Ardelyx Inc.

Start price
Target price
Perf. (%)
€0.99
30.11.21
€1.00
30.11.22
36.36%
11.12.21

Could be very worthwhile Investment >20% year
Good culture
Innovative
Few uniques
Bayer AG

Start price
Target price
Perf. (%)
€47.84
12.10.21
€45.00
12.10.22
-8.10%
06.12.21

Could be worthwhile Investment >10% per year
buy
Avid Bioservices Inc

Start price
Target price
Perf. (%)
€8.05
03.12.20
€9.00
03.12.21
200.62%
04.12.21